All 36 bispecific antibodies exhibited a dose-dependent response, with luciferase signal commencing at a concentration of 10 nM
Preclinical studies demonstrated that dual agonism could achieve greater glucose-lowering effects than either pathway alone
Important Clinical Trial Context: These trials were conducted separately under different protocols and patient populations
Measuring direct CBS activity provides more practical data than comparing expression of activity of CBS
Adipokines and bacterial metabolites: A pivotal molecular bridge linking obesity and gut microbiota dysbiosis to target
We believe this portfolio offers the potential to reshape the treatment landscape, bring innovative products to patients and deliver attractive returns to our shareholders. Also in September, the European Medicines Agency approved Novo Nordisks oral semaglutide (Rybelsus), the first to reduce cardiovascular death, heart attack, and stroke, according to the companys website